Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 6;14(11):e31159.
doi: 10.7759/cureus.31159. eCollection 2022 Nov.

Variability of Steroid Response Time in Polymyalgia Rheumatica: A Case Report

Affiliations
Case Reports

Variability of Steroid Response Time in Polymyalgia Rheumatica: A Case Report

Carter Gay et al. Cureus. .

Abstract

We present a unique case of a 75-year-old Caucasian female who presented with a two-month history of unrelenting proximal muscle pain and stiffness in the neck, shoulders, and pelvic girdle that lasted for 45 minutes each morning upon waking. Due to clinical suspicion of polymyalgia rheumatica (PMR), the patient was started on the standard therapy of low-dose glucocorticoid therapy and was noted to have a dramatic improvement in terms of pain, strength, mobility, and range of motion. Current literature shows high variability in the standard response time to treatment. Typical resolution of symptoms occurs within a span of one day to months. The case presented in our study shows symptom resolution as well as marked improvement in muscle strength and mobility within 12 hours. The purpose of this case report is to provide additional information for physicians when considering symptom-resolution time related to low-dose glucocorticoid therapy and PMR. Additionally, we briefly explore the literature on the correlation between giant cell arteritis (GCA) and glucocorticoid therapy for PMR as well as the data associated with adjuvant therapy using immunomodulatory treatment.

Keywords: inflammatory arthritis; low dose corticosteroids; muscle pain; pelvic girdle; polymyalgia rheumatica; shoulders.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Radiologic imaging
A) CT of the head revealed chronic findings without any acute intracranial abnormalities or neurovascular changes; B) X-ray of the right shoulder showed degenerative changes associated with mild osteoarthritis

References

    1. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. Dasgupta B, Salvarani C, Schirmer M, Crowson CS, Maradit-Kremers H, Hutchings A, Matteson EL. https://pubmed.ncbi.nlm.nih.gov/18050370/ J Rheumatol. 2008;35:270–277. - PubMed
    1. Polymyalgia rheumatica and giant cell arteritis: a systematic review. Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. JAMA. 2016;315:2442–2458. - PubMed
    1. Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy. Mori S, Koga Y. Clin Rheumatol. 2016;35:1367–1375. - PMC - PubMed
    1. Concise guidance: diagnosis and management of polymyalgia rheumatica. Bhaskar D. Clin Med. 2010;10:270–274. - PMC - PubMed
    1. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Hutchings A, Hollywood J, Lamping DL, et al. Arthritis Rheum. 2007;57:803–809. - PubMed

Publication types

LinkOut - more resources